Comment on "Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer," i.e., all we are saying is, give C a chance

Free Radic Biol Med. 2011 Jun 15;50(12):1726-7. doi: 10.1016/j.freeradbiomed.2011.03.030. Epub 2011 Apr 1.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Administration, Oral
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Ascorbic Acid / administration & dosage*
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives*
  • Drug Synergism
  • Gemcitabine
  • Humans
  • Injections, Intravenous
  • Mice
  • Pancreatic Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Deoxycytidine
  • Ascorbic Acid
  • Gemcitabine